TCAI becomes first US medical centre to use dual-energy ablation catheter
TCAI is the first to use Medtronic’s Affera mapping and ablation system with a Sphere-9 catheter since it received FDA clearance.
05 December 2024
05 December 2024
TCAI is the first to use Medtronic’s Affera mapping and ablation system with a Sphere-9 catheter since it received FDA clearance.
The five-year partnership will develop regulatory science tools to evolve the technical evaluation of paediatric medical devices.
US police have confirmed that the CEO of the insurance subsidiary was fatally shot outside an investor conference by a masked assailant.
The INSPIRA ART system features the HYLA blood sensor, a technology that provides continuous real-time blood monitoring.
The partnership will leverage Alamar’s ARGO HT System and NULISA platform.
Umberto Veronesi Foundation will fund the HER2DX test decision impact study project.
CleaRecon DL aims to improve cone-beam computed tomography image quality and will be available for GE HealthCare’s Allia systems.
The partnership is set to leverage Lisata's certepetide for usage with Kuva’s NanoMark platform technology.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.